Over the years, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work.
cancer research News
Remembering to take medication can be a struggle for anyone, but it’s usually a tougher challenge for teens and young adults with cancer. A recent study shows using a smartphone reminder app helps patients in this age group take medication as prescribed.
Post-doctoral fellow Andreana Holowatyj, PhD, received an award for her work studying colorectal cancer in young adults from the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.
Martin McMahon, PhD, and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.
Kali Dale, a graduate research assistant at HCI, was selected to receive the National Cancer Institute Graduate Diversity Supplement.
Immunotherapy has shown to be an effective treatment for several types of cancer. Is pancreatic cancer one of them? Ignacio Garrido-Laguna, MD, PhD, answers that question during Pancreatic Cancer Awareness Month.
Gurkan Mollaoglu, a graduate student in the Oliver Lab, received an F99 NCI Predoctoral to Postdoctoral Fellow Transition Award. This prestigious grant recognizes and supports outstanding graduate students who have demonstrated potential and interest in pursuing careers as independent cancer researchers.
“As a physician-scientist, the patients I’ve treated who haven’t made it are always in the back of my mind, moving my laboratory work forward,” says Michael Engel, MD, PhD. His research group studies the molecular details that lead to the development of childhood leukemias and then leverages that information to combat them.
Your body's metabolism is different from a cancer cell's metabolism. Researchers like graduate student Zhizhou Ye are studying how cancer cells rewire their metabolism to survive and grow. Understanding these processes in depth could lead to therapies that stop cancer's growth.
Volunteers are needed for a research study about quitting smoking. Participants will be compensated for their time and nicotine patches will be provided at no cost.
RNA modification is an area of cell biology few people have studied, and the idea of exploring the boundaries of the known world is what first attracted graduate student Archana Yerra to a career in science.
Our bodies fight cancer more than we really know, says Dr. Kenneth Grossmann. And, he adds, advances in medicine can help the immune system fight cancer even better.
Although sarcomas make up a small percentage of adult cancers and about 15 percent of childhood cancers, they are anything but small to the families they affect. The sarcoma program at Huntsman Cancer Institute is dedicated to finding better treatments and a cure for these cancers of the body’s connective tissues, bone, and muscles.
Governor Gary R. Herbert declared the week of June 19–24, 2017, as Cure Cancer Week in Utah. The proclamation comes during the week Huntsman Cancer Institute (HCI) at the University of Utah dedicates its major research expansion, the Primary Children’s and Families’ Cancer Research Center.
For Brain Tumor Awareness Month, Randy Jensen, MD, PhD, wants you to know something: “There is a lot of hope for patients with brain tumors.”
Mary Beckerle, PhD, testified before the United States House of Representatives Committee on Oversight and Government Reform on the impact of federally-funded cancer research.
Huntsman Cancer Institute researcher Andrew Hahn, MD, received the Conquer Cancer Foundation of ASCO Merit Award. The award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.
Biomedical research helps develop safe and effective disease treatments for all citizens. The 21st Century Cures Act, signed into law in December 2016, includes $4.8 billion to fund research and drug development. The law includes funds for the “Cancer Moonshot,” which seeks to accelerate cancer research in the United States. Cancer researchers at HCI urge the community to continue to support biomedical research.
On September 7, 2016, National Cancer Institute (NCI) Acting Director Douglas Lowy, MD, accepted the recommendations of the Cancer Moonshot Blue Ribbon Panel (BRP) on a set of scientific approaches to accelerate progress in cancer research. An overview of the report was published in the journal Science.